Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05001347
Title A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ) in Patients With Ovarian Cancer and Selected Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors I-Mab Biopharma US Limited
Indications

fallopian tube cancer

ovarian cancer

triple-receptor negative breast cancer

head and neck squamous cell carcinoma

gastric adenocarcinoma

lung non-small cell carcinoma

gastroesophageal adenocarcinoma

ovary epithelial cancer

Therapies

Uliledlimab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.